Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -7 of 7
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
8/22/2008
 
First Published:
7/24/2007
1.
Phase III Randomized Study of Biliary Stenting With Versus Without Photodynamic Therapy Using Porfimer Sodium in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma and Other Biliary Tract Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
Other
CRUK-PHOTOSTENT-02
EU-20740, EUDRACT-2005-001173-96, ISRCTN87712758, CTA-20363/0207/001-0001, NCT00513539
2.
Efficiency Evaluation of Photodynamic Therapy With Photofrin® on Unresectable Type III or IV Cholangiocarcinomas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Approved-not yet active
18 and over
Other
PHRC 2006-01
NCT00540735
3.
Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
18 and over
Other
WBPDT-577-04
NCT00322699
First Published:
3/22/2007
4.
Phase II Study of Photodynamic Therapy With Porfimer Sodium in Patients With Pre-Malignant or Malignant Lesions or Condemned Mucosa Syndrome in the Upper Aerodigestive Tract
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
Over 18
Other
SCCC-2002103
EPROST-20020618, SCCC-02/618C, SCCC-20050715, SCCC-20020618, NCT00453336
Last Modified:
5/22/2008
 
First Published:
1/24/2008
5.
Phase II Study of Intraoperative Pleural Photodynamic Therapy Using Porfimer Sodium (Photofrin®) in Patients With Primary Resectable Non-Small Cell Lung Cancer and Pleural Spread
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
UPCC-05503
709070, UPCC-709070, NCT00601848
First Published:
9/12/2007
6.
Phase I Pilot Study of Photodynamic Therapy Using Porfimer Sodium in Patients With Recurrent Oral Cavity or Laryngeal Dysplasia or Recurrent In Situ or Stage I Squamous Cell Carcinoma of the Oral Cavity or Larynx
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
NCI
RPCI-RPC-01-08
RPC 01-08, NCT00530088
Last Modified:
12/28/2008
 
First Published:
9/15/2008
7.
Study of Photodynamic Therapy Using Porfimer Sodium in Patients With Non-Small Cell Lung Cancer With Obstructive or Hemorrhagic Endobronchial Disease
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Biomarker/Laboratory analysis, Treatment
Active
Not specified
NCI
OSU-07115
OSU 07115, OSU-2008C0055, NCT00754910
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute